Dr. Ming-Tseh Lin is an associate professor of pathology at the Johns Hopkins University School of Medicine and serves as the director of the Department of Pathology’s Molecular Diagnostics Laboratory.
A molecular pathologist, Dr. Lin is an expert in the development and validation of new assays, including the clinical application of next-generation sequencing (NGS) platforms.
Because he initially practiced as a hematologist and bone-marrow transplant specialist, Dr. Lin has a unique perspective on molecular diagnostics.
Dr. Lin earned his medical and doctoral degrees at National Taiwan University Medical School and Hospital (Taipei), where he trained in internal medicine and hematology. He completed pathology residencies at The Johns Hopkins Hospital and Albany Medical College, as well as two pathology fellowships at Hopkins.
Dr. Lin has published more than 100 academic journal articles. He is certified in molecular genetic pathology and anatomic pathology by the American Board of Pathology.
Dr. Lin is an expert in the development and validation of new assays, including the clinical application of next-generation sequencing (NGS) platforms.
His current research aims to identify cancer biomarkers.
In addition, investigators in the CLIA-certified Molecular Diagnostics Laboratory led by Dr. Lin have validated the NGS platform for mutation detection of formalin-fixed, paraffin-embedded neoplastic tissues.
Dr. Lin has previously studied the association between single- nucleotide polymorphisms and the outcomes of patients who underwent hematopoietic cell transplantation.
Zheng G, Tseng LH, Chen G, Haley L, Illei P, Gocke CD, Eshleman JR, Lin MT. Clinical detection and categorization of uncommon and concomitant mutations involving BRAF. BMC Cancer. 2015;15:779.
Haley L, Tseng LH, Zheng G, Dudley J, Anderson DA, Azad NS, Gocke CD, Eshleman JR, Lin MT. Performance characteristics of next-generation sequencing in clinical mutation detection of colorectal cancers. Mod Pathol. 2015;28:1390-9.
Lin MT, Mosier SL, Thiess M, Beierl KF, Debeljak M, Tseng LH, Chen G, Yegnasubramanian S, Ho H, Cope L, Wheelan SJ, Gocke CD, Eshleman JR. Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing. Am J Clin Pathol. 2014;141:856-66.
Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, Hansen JA. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003; 349:2201-10.